Learn more about clinical trials at this NCCN Member Institution.
The Mayo Clinic Cancer Center is a National Cancer Institute-designated comprehensive cancer center with a multisite presence. Its three campuses — in Phoenix/Scottsdale, Ariz., Jacksonville, Fla., and Rochester, Minn. — give the Mayo Clinic Cancer Center a broad geographic reach, enabling it to serve diverse patient populations around the world. More than 135,000 cancer patients come to Mayo Clinic each year.
The Mayo Clinic Cancer Center has 10 major cancer research programs that translate scientific discoveries in the laboratory into leading-edge treatments and therapies for patients.
The Mayo Clinic Cancer Center receives more than $140 million in competitive peer review grants, including the NCI's highly sought Specialized Programs of Research Excellence (SPORE) grants. The Mayo Clinic Cancer Center has four NCI SPORE grants and one SPORE grant that is shared with another institution. These grants support research in brain cancer, breast cancer, ovarian cancer, pancreatic cancer and lymphoma.
Mayo Clinic's philosophy of patient care, laid out 150 years ago, emphasizes developing medicine as a cooperative science with the clinician and the laboratory scientist uniting for the good of the patient. That philosophy, still so relevant today, enables more than 1,000 outstanding Mayo Clinic physicians, care providers and researchers to form productive collaborations across cancer programs and specialties. Their collective knowledge enhances the potential for breakthroughs in cancer research and treatment.
Mayo Clinic Cancer Center is dedicated to understanding the biology of cancer, to discovering new ways to predict, prevent, diagnose and treat cancer, and to transforming the quality of life for cancer patients today and in the future.